DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita

Molecular and Cellular Biology

Volumn 17, Issue 3, 1997, Pages 1476-1483

  Ito, Masafumi ^a   Yu, Richard ^a   Jameson, J Larry ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; COMPLEMENTARY DNA; TRANSCRIPTION FACTOR;

ADRENAL DISEASE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CONTROLLED STUDY; DNA TRANSFECTION; EMBRYO; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGONADOTROPIC HYPOGONADISM; HYPOPLASIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA BINDING; TRANSACTIVATION; X CHROMOSOME LINKED DISORDER;

ANIMALIA;

EID: 0031020234     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.3.1476     Document Type: Article

References (53)

1. Albarracin, C. T., U. B. Kaiser, and W. W. Chin. 1994. Isolation and characterization of the 5′-flanking region of the mouse gonadotropin-releasing hormone receptor gene. Endocrinology 135:2300-2306.
2. Baeuerle, P. A., and D. Baltimore. 1988. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242:540-546.
3. Barnhart, K. M., and P. L. Mellon. 1994. The orphan nuclear receptor, steroidogenic factor-1, regulates the glycoprotein hormone alpha-subunit gene in pituitary gonadotropes. Mol. Endocrinol. 8:878-885.
4. Benezra, R., R. L. Davis, D. Lockshon, D. L. Turner, and H. Weintraub. 1990. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-59.
5. Burris, T. P., Z. Nawaz, M. J. Tsai, and B. W. O'Malley. 1995. A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors. Proc. Natl. Acad. Sci. USA 92: 9525-9529.
6. Cavailles, V., S. Dauvois, F. L'Horset, G. Lopez, S. Hoare, P. J. Kushner, and M. G. Parker. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:3741-3751.
7. Chatterjee, V. K. K., J. K. Lee, A. Rentoumis, and J. L. Jameson. 1989. Negative regulation of the thyroid-stimulating hormone alpha gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proc. Natl. Acad. Sci. USA 86:9114-9118.
8. Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
9. Chu, R., L. D. Madison, Y. Lin, P. Kopp, M. S. Rao, J. L. Jameson, and J. K. Reddy. 1995. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways. Proc. Natl. Acad. Sci. USA 92:11593-11597.
10. Clemens, J. W., D. S. Lala, K. L. Parker, and J. S. Richards. 1994. Steroidogenic factor-1 binding and transcriptional activity of the cholesterol side-chain cleavage promoter in rat granulosa cells. Endocrinology 134:1499-1508.
11. deWet, J. R., K. V. Wood, M. DeLuca, and D. R. Helinski. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:725-737.
12. Graham, F. L., and A. J. van der Eb. 1973. Transformation of rat cells by DNA of human adenovirus 5. Virology 52:456-487.
13. Guo, W., J. S. Mason, C. G. Stone, Jr., S. A. Morgan, S. I. Madu, A. Baldini, E. A. Lindsay, L. G. Biesecker, K. C. Copeland, M. N. Horlick et al. 1995. Diagnosis of X-linked adrenal hypoplasia congenita by mutation analysis of the DAX1 gene. JAMA 274:324-330.
14. Habiby, R. L., P. Boepple, L. Nachtigall, P. M. Sluss, W. F. Crowley, and J. L. Jameson. 1996. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J. Clin. Invest. 98:1055-1062.
15. Halachmi, S., E. Marden, G. Martin, H. MacKay, C. Abbondanza, and M. Brown. 1994. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458.
16. Halvorson, L. M., U. B. Kaiser, and W. W. Chin. 1996. Stimulation of luteinizing hormone beta gene promoter activity by the orphan nuclear receptor, steroidogenic factor-1. J. Biol. Chem. 271:6645-6650.
17. Hatano, O., K. Takayama, T. Imai, M. R. Waterman, A. Takakusu, T. Omura, and K. Morohashi. 1994. Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development 120:2787-2797.
18. Honda, S., K. Morohashi, M. Nomura, H. Takeya, M. Kitajima, and T. Omura. 1993. Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J. Biol. Chem. 268:7494-7502.
19. Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. K. Glass et al. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
20. Ikeda, Y., X. Luo, R. Abbud, J. H. Nilson, and K. L. Parker. 1995. The nuclear factor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol. Endocrinol. 9:478-486.
21. Ingraham, H. A., D. S. Lala, Y. Ikeda, X. Luo, W. H. Shen, M. W. Nachtigal, R. Abbud, J. H. Nilson, and K. L. Parker. 1994. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev. 8:2302-2312.
22. Ito, M., and J. L. Jameson. Unpublished data.
23. Ito, M., Y. Mori, Y. Oiso, and H. Saito. 1991. A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus. J. Clin. Invest. 87:725-728.
24. Jow, L., and R. Mukherjee. 1995. The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPAR alpha and thyroid hormone receptors. J. Biol. Chem. 270:3836-3840.
25. Juge-Aubry, C. E., A. Gorla-Bajszczak, A. Pernin, T. Lemberger, W. Wahli, A. G. Burger, and C. A. Meier. 1995. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat. J. Biol. Chem. 270:18117-18122.
26. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.-C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
27. Keri, R. A., and J. H. Nilson. 1996. A steroidogenic factor-1 binding site is required for activity of the luteinizing hormone beta subunit promoter in gonadotropes of transgenic mice. J. Biol. Chem. 271:10782-10785.
28. Kletter, G. B., J. L. Gorski, and R. P. Kelch. 1991. Congenital adrenal hypoplasia and isolated gonadotropin deficiency. Trends Endocrinol. Metab. 2:123-128.
29. Lala, D. S., D. A. Rice, and K. L. Parker. 1992. Steroidogenic factor 1, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fush tarazu-factor 1. Mol. Endocrinol. 6:1249-1258.
30. 3 response: hormonal cross talk by ligand-induced squelching. Mol. Cell. Biol. 13:7698-7707.
31. Luo, X., Y. Ikeda, and K. L. Parker. 1994. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481-490.
32. Lynch, J. P., D. S. Lala, J. J. Peluso, W. Luo, K. L. Parker, and B. A. White. 1993. Steroidogenic factor 1, an orphan nuclear receptor, regulates the expression of the rat aromatase gene in gonadal tissues. Mol. Endocrinol. 7:776-786.
33. Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835-839.
34. Margolskee, R. F., B. McHendry-Rinde, and R. Horn. 1993 Panning transfected cells for electrophysiological studies. BioTechniques 15:906-911.
35. Marsden, H. B., and H. D. Zakhour. 1978. Cytomegalic adrenal hypoplasia with pituitary cytomegaly. Virchows Arch. A Pathol. Pathol. Anat. 378:105-110.
36. Morohashi, K., S. Honda, Y. Inomata, H. Handa, and T. Omura. 1992. A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. J. Biol. Chem. 267:17913-17919.
37. Morohashi, K., U. M. Zanger, S. Honda, M. Hara, M. R. Waterman, and T. Omura. 1993. Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor. Ad4BP. Mol. Endocrinol. 7:1196-1204.
38. Muscatelli, F., T. M. Strom, A. P. Walker, E. Zanaria, D. Recan, A. Meindl, B. Bardoni, S. Guioli, G. Zehetner, W. Rabl et al. 1994. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372:672-676.
39. Nagaya, T., and J. L. Jameson. 1993. Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. J. Biol. Chem. 268:15766-15771.
40. Onate, S. A., S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
41. Prader, A., M. Zachmann, and R. Illig. 1975. Luteinizing hormone deficiency in hereditary congenital adrenal hypoplasia. J. Pediatr. 86:421-422.
42. Ron, D., and J. F. Habener. 1992. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6:439-453.
43. Sadovsky, Y., P. A. Crawford, K. G. Woodson, J. A. Polish, M. A. Clements, L. M. Tourtellotte, K. Simburger, and J. Milbrandt. 1995. Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad. Sci. USA 92:10939-10943.
44. Sadowski, I., J. Ma, S. Triezenberg, and M. Ptashne. 1988. Ga14-VP16 is an unusually potent transcriptional activator. Nature 335:563-564.
45. Seol, W., H.-S. Choi, and D. D. Moore. 1996. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272:1336-1339.
46. Shapiro, D. J., P. A. Sharp, W. W. Wahli, and M. J. Keller. 1988. A high-efficiency HeLa cell nuclear transcription extract. DNA 7:47-55.
47. Shen, W. H., C. C. Moore, Y. Ikeda, K. L. Parker, and H. A. Ingraham. 1994. Nuclear receptor steroidogenic factor 1 regulates the mullerian inhibiting substance gene: a link to the sex determination cascade. Cell 77:651-661.
48. Shrivastava, A., S. Saleque, G. V. Kalpana, S. Artandi, S. P. Goff, and K. Calame. 1993. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 262:1889-1892.
49. Sieweke, M. H., H. Tekotte, J. Frampton, and T. Graf. 1996. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell 85:49-60.
50. Swain, A., E. Zanaria, A. Hacker, R. Lovell-Badge, and G. Camerino. 1996. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat. Genet. 12:404-409.
51. Windle, J. J., R. I. Weiner, and P. L. Mellon. 1990. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol. Endocrinol. 4:597-603.
52. Yanase, T., R. Takayanagi, K. Oba, Y. Nishi, K. Ohe, and H. Nawata. 1996. New mutations of DAX-1 genes in two Japanese patients with X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 81:530-535.
53. Zanaria, E., F. Muscatelli, B. Bardoni, T. M. Strom, S. Guioli, W. Guo, E. Lalli, C. Moser, A. P. Walker, E. R. McCabe et al. 1994. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372:635-641.